HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Addition of a novel, protective family history category allows better profiling of cardiovascular risk and atherosclerotic burden in the general population. The Asklepios Study.

AbstractOBJECTIVES:
Whereas the importance of family history (FH) is widely recognized in cardiovascular risk assessment, its full potential could be underutilized, when applied with its current simple guidelines-based definition (cFH): presence of premature cardiovascular disease (CVD) in a first-degree relative. We tested the added value of a new, extended family history definition (eFH), also taking into account later onset of disease, second-degree relatives and number of affected relatives, on profiling cardiovascular risk and atherosclerotic burden in the general population.
DESIGN:
Longitudinal population study.
SETTING:
Random, representative population sample from Erpe-Mere and Nieuwerkerken (Belgium, primary care).
SUBJECTS:
2524 male/female volunteers, aged 35-55 years, free from overt CVD.
MAIN OUTCOME MEASURES:
Subjects were extensively phenotyped including presence of atherosclerosis (ultrasound) and a newly developed FH questionnaire (4 generations).
RESULTS:
Compared to cFH, eFH was superior in predicting an adverse risk profile (glycemic state, elevated blood pressure, lipid abnormalities, presence of metabolic syndrome components) and presence of atherosclerosis (all age & sex-adjusted p<0.05). Unlike cFH, eFH remained a significant predictor of subclinical atherosclerosis after adjusting for confounders. Most relations with eFH were not graded but showed clear informational breakpoints, with absence of CVD (including late onset) in any first-degree relative being a negative predictor of atherosclerosis, and a particularly interesting phenotype for further study.
CONCLUSIONS:
A novel, extended FH definition is superior to the conventional definition in profiling cardiovascular risk and atherosclerotic burden in the general population. There remain clear opportunities to refine and increase the performance and informational content of this simple, readily-available inexpensive tool.
AuthorsCaroline M Van daele, Tim De Meyer, Marc L De Buyzere, Thierry C Gillebert, Simon L I J Denil, Sofie Bekaert, Julio A Chirinos, Patrick Segers, Guy G De Backer, Dirk De Bacquer, Ernst R Rietzschel, Asklepios Investigators
JournalPloS one (PLoS One) Vol. 8 Issue 5 Pg. e63185 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID23658806 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Atherosclerosis (diagnosis, epidemiology, pathology, physiopathology)
  • Coronary Vessels (pathology, physiopathology)
  • Family
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phenotype
  • Risk Assessment (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: